JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ilic, M. Z.
Right arrow Articles by Handley, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ilic, M. Z.
Right arrow Articles by Handley, C. J.

J Biol Chem, Vol. 273, Issue 28, 17451-17458, July 10, 1998

Characterization of Aggrecan Retained and Lost from the Extracellular Matrix of Articular Cartilage
INVOLVEMENT OF CARBOXYL-TERMINAL PROCESSING IN THE CATABOLISM OF AGGRECAN

Mirna Z. IlicDagger , H. Clem Robinson§, and Christopher J. HandleyDagger

From the Dagger  School of Human Biosciences, La Trobe University, Bundoora 3083, Victoria, Australia and the § Department of Biochemistry and Molecular Biology, Monash University, Clayton 3168, Victoria, Australia

The catabolism of aggrecan in bovine articular cartilage explants is characterized by the release into the culture medium of high molecular weight aggrecan fragments, generated by the proteolytic cleavage of the core protein between residues Glu373 and Ala374 within the interglobular domain. In this study, the position of the carboxyl-terminus of these aggrecan fragments, as well as a major proteolytically shortened aggrecan core protein present in cartilage matrix, have been deduced by characterizing the peptides generated by the reaction of aggrecan core protein peptides with cyanogen bromide. It was shown that two out of three such peptide fragments having an amino terminus starting at Ala374 have their carboxyl terminus located within the chondroitin sulfate 1 domain. The third and largest aggrecan core protein peptide, with an amino terminus starting at Ala374, has a carboxyl terminus in a region of core protein between the chondroitin sulfate 1 domain and the chondroitin sulfate 2 domain. The carboxyl terminus of this peptide appeared to be the same as that of the proteolytically degraded aggrecan core protein, which is retained within the extracellular matrix of the tissue. Another two aggrecan fragments recovered from the medium of explant cultures with amino-terminal sequences in the chondroitin sulfate 2 domain at Ala1772 and Leu1872 were shown to have their carboxyl termini within the G3 globular domain. These results suggest that the catabolism of aggrecan between residues Glu373 and Ala374 in the interglobular domain by the putative proteinase, aggrecanase, may be dependent on prior proteolytic processing within the carboxyl-terminal region of the core protein.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Z. Ilic, C. J. East, F. M. Rogerson, A. J. Fosang, and C. J. Handley
Distinguishing Aggrecan Loss from Aggrecan Proteolysis in ADAMTS-4 and ADAMTS-5 Single and Double Deficient Mice
J. Biol. Chem., December 28, 2007; 282(52): 37420 - 37428.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. East, H. Stanton, S. B. Golub, F. M. Rogerson, and A. J. Fosang
ADAMTS-5 Deficiency Does Not Block Aggrecanolysis at Preferred Cleavage Sites in the Chondroitin Sulfate-rich Region of Aggrecan
J. Biol. Chem., March 23, 2007; 282(12): 8632 - 8640.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. B. Little, C. T. Meeker, R. M. Hembry, N. A. Sims, K. E. Lawlor, S. B. Golub, K. Last, and A. J. Fosang
Matrix Metalloproteinases Are Not Essential for Aggrecan Turnover during Normal Skeletal Growth and Development
Mol. Cell. Biol., April 15, 2005; 25(8): 3388 - 3399.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-M. Malfait, R.-Q. Liu, K. Ijiri, S. Komiya, and M. D. Tortorella
Inhibition of ADAM-TS4 and ADAM-TS5 Prevents Aggrecan Degradation in Osteoarthritic Cartilage
J. Biol. Chem., June 14, 2002; 277(25): 22201 - 22208.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Tortorella, M. Pratta, R.-Q. Liu, J. Austin, O. H. Ross, I. Abbaszade, T. Burn, and E. Arner
Sites of Aggrecan Cleavage by Recombinant Human Aggrecanase-1 (ADAMTS-4)
J. Biol. Chem., June 9, 2000; 275(24): 18566 - 18573.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Fosang, K. Last, H. Stanton, D. B. Weeks, I. K. Campbell, T. E. Hardingham, and R. M. Hembry
Generation and Novel Distribution of Matrix Metalloproteinase-derived Aggrecan Fragments in Porcine Cartilage Explants
J. Biol. Chem., October 13, 2000; 275(42): 33027 - 33037.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. A. Mercuri, R. A. Maciewicz, J. Tart, K. Last, and A. J. Fosang
Mutations in the Interglobular Domain of Aggrecan Alter Matrix Metalloproteinase and Aggrecanase Cleavage Patterns. EVIDENCE THAT MATRIX METALLOPROTEINASE CLEAVAGE INTERFERES WITH AGGRECANASE ACTIVITY
J. Biol. Chem., October 13, 2000; 275(42): 33038 - 33045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.